A股異動丨精測電子漲停 國家集成電路產業投資基金入股上海精測半導體
格隆匯12月24日丨精測電子(300567.SZ)漲停,報51.32元,總市值126億元。天眼查顯示,精測電子控股子公司上海精測半導體技術有限公司已完成股權變更,獲國家集成電路產業投資基金股份有限公司大比例投資入股。公司註冊資本由1億元大比例增加到6.5億元。其中國家集成電路產業投資基金股份有限公司在精測半導體中持股15.38%,位列第二大股東。精測電子持股46.15%,仍為精測半導體控股股東。精測電子主營業務為平板顯示檢測系統的研發、生產與銷售,主營產品包括模組檢測系統、面板檢測系統、OLED檢測系統等。公司在Module製程技術水平處於行業前列。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.